ProbiusDx
Probius is a deep-tech company bridging the data gap between biology and AI to revolutionize biomedical research and healthcare. Their core technology, Quantum Electrochemical Spectroscopy (QES), creates a unique digital twin of biological specimens by representing biochemistry as vibrational signatures. This enables the decentralized and scalable collection of multidimensional biological datasets for AI analysis, accelerating research from disease discovery to drug development and therapy monitoring. The QES platform offers a simple, reagent-free workflow that detects and quantifies thousands of analytes from minimal sample volumes in minutes, supporting applications in biomarker discovery, pre-clinical studies, and quality control.
ProbiusDx
Probius is a deep-tech company bridging the data gap between biology and AI to revolutionize biomedical research and healthcare. Their core technology, Quantum Electrochemical Spectroscopy (QES), creates a unique digital twin of biological specimens by representing biochemistry as vibrational signatures. This enables the decentralized and scalable collection of multidimensional biological datasets for AI analysis, accelerating research from disease discovery to drug development and therapy monitoring. The QES platform offers a simple, reagent-free workflow that detects and quantifies thousands of analytes from minimal sample volumes in minutes, supporting applications in biomarker discovery, pre-clinical studies, and quality control.
TL;DR
Founded: 2016
Headquarters: El Cerrito / Fremont area, California, United States
Core tech: Quantum Electrochemical Spectroscopy (QES) — reagent-free electronic sensing
Employees: ~16
Total funding (reported): USD 12,900,000
Investors (examples): Cota Capital, Heuristic Capital, Zoic Capital, Stanford University
Company Overview
Problem Domain
Bridging the data gap between biological samples and AI-driven analysis for diagnostics, biomarker discovery, and translational research.
Founded
2016
Industry
Biotechnology
Tech Stack
Funding Track Record
Investor Signal
“Cota Capital, Heuristic Capital, Zoic Capital, Stanford University, Cota Capital listed as lead for Series A”